Delayed imaging to distinguish bone lesions from urinary tract activity

Area of Science:

• Nuclear medicine
• Radiopharmacology

Background:

• Bone imaging utilizes radiopharmaceuticals like technetium-99m (99mTc)-labeled polyphosphate or diphosphonate.
• These agents are used to detect bone abnormalities and metastases.

Observation:

• Early imaging (2 hours post-injection) revealed significant radiotracer activity within the urinary tract.
• This urinary activity frequently obscured the visualization of the bony pelvis in a substantial number of patients (28/1,400).

Findings:

• Pelvic assessment was compromised, ranging from difficult to impossible in initial imaging.
• Obtaining delayed images 24 hours after radiopharmaceutical administration demonstrated reduced urinary tract activity.
• Delayed imaging significantly improved the visualization of the bony pelvis.

Implications:

• Standard early bone imaging protocols may hinder accurate pelvic bone assessment.
• A 24-hour delayed imaging protocol is recommended to overcome urinary tract interference.
• Optimizing imaging timing can enhance diagnostic confidence in pelvic bone evaluations using 99mTc-labeled phosphates.